stars 1 stars 2 stars 3

REGENHU, the Swiss Med Tech 3D Bioprinting pioneer, started in 2007 with the goal to create and develop bioprinting technologies that will positively impact medicine. Today we remain strong believers in this vision and are driven to its realization. We are an ambitious, passionate and dynamic team that are building research 3D Bioprinters and software for our customers today, with the view to creating the instruments that will provide their manufacturing needs of the future. Our customer focused approach, visionary outlook, advanced instruments and user-friendly software that perform their tasks with accuracy and repeatability, are at the heart of everything REGENHU does. Our commitment to our users, present and future, is that we will stay with them through their journey, with bioprinting instruments that enhance their ability to realize their research goals, however ambitious. With our instruments the REGENHU team are bringing the future closer, we are revolutionizing medicine today.

REGENHU Questions

The REGENHU annual revenue was $811000 in 2026.

12 people are employed at REGENHU.

The NAICS codes for REGENHU are [541713, 541, 54171, 5417, 54].

The SIC codes for REGENHU are [873, 87].

Top REGENHU Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users